RachelDavisMD

Ophthalmology • Akron, OH

Oculo-Plastic & Orbital Reconstructive Surgery

Northeast Ohio Eye Surgeons

Join to view full profile

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Davis' full profile

Already have an account?

Office
4099 Embassy Parkway
Akron, OH 44333
Is this information wrong?

Education & Training

Allegheny General HospitalFellowship, Ophthalmic Plastic and Reconstructive Surgery, 2020 - 2021
University of Cincinnati Medical Center/College of MedicineResidency, Ophthalmology, 2017 - 2020
Alameda Health System-Highland HospitalResidency, Internal Medicine, 2016 - 2017
Case Western Reserve University School of MedicineClass of 2016

Certifications & Licensure

OH State Medical License 2017 - 2025
PA State Medical License 2020 - 2022

Publications & Presentations

PubMed

A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice.
Griffith, A. D.,Zaidi, A. K.,Pietro, A.,Hadiono, M.,Yang, J. S.,Davis, R.,Popkin, D. L.> ;Sci Rep. 2018 Sep 29

Journal Articles

Management of cicatrizing disorders
Kasey Pierson, MD; Rachel Davis, MD; Jonathan Pargament, MD, Focal Points, 12/2019
A Requirement for slc15a4 in Imiquimod-Induced Systemic Inflammation and Psoriasiform Inflammation in Mice
Rachel Davis, MD, Nature

Abstracts/Posters

Teprotumumab treatment in a patient with long-standing Thyroid Eye Disease
Rachel Davis, MD; James Williams, MD; Cara Amatangelo; Erik Happ, MD, NANOS Annual Meeting, 2/2021

Hospital Affiliations

Summa Health System – Akron CampusAkron, Ohio